Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Michael Quigley, Chan Gao et al.|Unknown|2023Cited by 0
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Michael Quigley, Chan Gao et al.|Unknown|2023Cited by 0
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Michael Quigley, Chan Gao et al.|Unknown|2023Cited by 0
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Michael Quigley, Chan Gao et al.|Unknown|2023Cited by 0
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Michael Quigley, Chan Gao et al.|Unknown|2023Cited by 0